#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Biliary neoplasm Cerebral arteriovenous malformation haemorrhagic Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Adrenoleukodystrophy Hereditary angioedema with C1 esterase inhibitor deficiency Obesity Pustular psoriasis Cystic fibrosis gastrointestinal disease Vascular calcification Sarcoma Hereditary optic atrophy Parkinson's disease Multiple system atrophy Tuberous sclerosis complex Pancreatic carcinoma More trials…

    Learn about Rare Diseases

    Haemolytic uraemic syndrome – Trials in Disease Ornithine transcarbamoylase deficiency – Basic Information Haemophilia A without inhibitors – Trials in Disease Waldenstrom’s macroglobulinaemia recurrent – Trials in Disease Antithrombin III deficiency – Trials in Disease Retinitis pigmentosa – Diagnostics Friedreich’s ataxia Medulloblastoma recurrent – Diagnostics Haemophilia B with anti factor IX – Treatment Hereditary angioedema – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSKVX000000040033 Vortioxetine Tadekinig Alfa Human Coagulation Factor Vii Dexchlorpheniramine Elasomeran Hydrocortisone Oxygen Ph.eur. Cedazuridine M1P Dipotassium Salt Nitrous Oxide Ganciclovir Sodium Rbd4059 COLESEVELAM HYDROCHLORIDE Imatinib Enoxaparin Sodium Bimekizumab Dutasteride Omp10 Cemiplimab More therapies…

    Learn about Your Condition

    Cardiac valve disease Constipation Head and neck cancer stage III Tonsillitis Spinal cord injury cervical Round cell liposarcoma Generalised anxiety disorder Stomatitis Niemann-Pick disease Chronic lymphocytic leukaemia Vascular calcification Cerebral palsy Vasospasm Follicular lymphoma stage IV Dystonic tremor More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Type 2 diabetes mellitus

  • Study comparing RO7795081 and semaglutide with placebo in adults with type 2 diabetes mellitus

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • RO7795081
    • Semaglutide
    Hungary Poland Spain

  • Study of Orforglipron for Weight Management in People with Obesity or Overweight, With or Without Type 2 Diabetes

    Not recruiting

    3 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Obesity
    • Overweight
    Czechia Germany

  • Study on Insulin Aspart for Recovery from Low Blood Sugar in People with and without Type 2 Diabetes

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Insulin Aspart
    Austria

  • Study on Personalized Treatment Using Dapagliflozin, Dulaglutide, and Metformin for Patients with Uncontrolled Type 2 Diabetes

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Canagliflozin
    • Dulaglutide
    • Linagliptin
    Spain

  • Study on the Effectiveness of Survodutide for Weight Loss in Patients with Type 2 Diabetes and Obesity

    Not recruiting

    3 1
    Investigated Drugs:
    • BI 456906
    • SURVODUTIDE
    Belgium Czechia Denmark Finland Germany Greece +5

  • Study on Preventing Heart Disease in Diabetes Patients Using Eprosartan Mesilate and Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Bisoprolol Fumarate
    • Captopril
    • Cilazapril
    Austria Spain
Previous Page
1 … 6 7 8 9 10 … 13
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!